D. Mckenna

发表

Platelet serotonin uptake sites increased in drinkers ofayahuasca

J. Callaway, M. Airaksinen, D. Mckenna, 1994, Psychopharmacology.

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

D. Mckenna, A. Szabo, M. Winkelman, 2013, Journal of Neural Transmission.

Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain.

C. Mathis, J. Saavedra, D. Mckenna, 1987, European journal of pharmacology.

Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand

D. E. Nichols, C. Mathis, J. Saavedra, 1989, Brain Research.

Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin

S. Peroutka, D. Mckenna, D. McKenna, 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.

D. Mckenna, K. Jones, K. Hughes, 2001, Alternative therapies in health and medicine.

Green tea monograph.

D. Mckenna, K. Jones, K. Hughes, 2000, Alternative therapies in health and medicine.

Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

S. Peroutka, D. Mckenna, Stephen J. Peroutka, 1990, Journal of neurochemistry.

The Therapeutic Potential of Ayahuasca

D. Mckenna, Michael A. Coe, 2017 .

Ayahuasca and Human Destiny

D. Mckenna, 2005, Journal of psychoactive drugs.

1 Ayahuasca : An Ethnopharmacologic History

D. Mckenna, 2003 .

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.

D. Mckenna, G. Towers, F. Abbott, 1984, Journal of ethnopharmacology.

A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.

J. Callaway, D. Mckenna, C. Grob, 2006, Journal of analytical toxicology.

Plant hallucinogens: springboards for psychotherapeutic drug discovery

D. Mckenna, 1995, Behavioural Brain Research.

Pharmacokinetics of Hoasca alkaloids in healthy humans.

R. Poland, J. Callaway, D. Mckenna, 1999, Journal of ethnopharmacology.

Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens.

D. Mckenna, G. Towers, F. Abbott, 1984, Journal of ethnopharmacology.

On the comparative ethnopharmacology of malpighiaceous and myristicaceous hallucinogens.

D. Mckenna, G. Towers, 1985, Journal of psychoactive drugs.

Binding Potency of Paroxetine Analogues for the 5‐Hydroxytryptamine Uptake Complex *

C. Mathis, J. Gerdes, S. Peroutka, 1992, The Journal of pharmacy and pharmacology.

Autoradiographic localization of 5HT2 receptors in rat brain using [125I]-DOI, a selective psychotomimetic radioligand

J. Saavedra, D. Mckenna, A. Nazarali, 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Scientific Investigation of Ayahuasca: A Review of Past and Current Research

D. Mckenna, C. Grob, 1999 .

Biochemistry and Pharmacology of Tryptamines and β-Carbolines A Minireview

D. Mckenna, G. Towers, 1984 .

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

D. Mckenna, 2004, Pharmacology & therapeutics.

Receptor screening technologies in the evaluation of Amazonian ethnomedicines with potential applications to cognitive deficits.

B. Roth, T. Hoye, D. Mckenna, 2011, Journal of ethnopharmacology.

Ultra-violet mediated cytotoxic activity of β-carboline alkaloids

D. Mckenna, G. Towers, G. Towers, 1981 .

The Incense Bible: Plant Scents That Transcend World Culture, Medicine, and Spirituality

D. Mckenna, K. Hughes, 2007 .

Botanical Medicines: The Desk Reference for Major Herbal Supplements

D. Mckenna, K. Jones, K. Hughes, 2002 .

Morphological, phytochemical, and genetic variation in hawaiian cultivars of ’Awa (Kava,Piper methysticum, piperaceae)

Q. Zheng, D. Mckenna, V. Lebot, 1999, Economic Botany.

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

S. Peroutka, D. Mckenna, S. J. Peroutka, 1990, Neuropharmacology.

Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.

J. Callaway, D. Mckenna, G. S. Brito, 1996, Journal of analytical toxicology.

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

D. Mckenna, A. Shulgin, X. Guan, 1991, Pharmacology Biochemistry and Behavior.

Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain

D. Mckenna, 1989 .

Black cohosh: efficacy, safety, and use in clinical and preclinical applications.

D. Mckenna, K. Jones, K. Hughes, 2001, Alternative therapies in health and medicine.

Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain.

J. Saavedra, D. Mckenna, A. Nazarali, 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Coenzyme Q-10: efficacy, safety, and use.

D. Mckenna, Laurie K Mischley, K. Jones, 2002, Alternative therapies in health and medicine.

Ginseng and warfarin interactions.

Kenji Watanabe, D. Mckenna, Kenji Watanabe, 2004, Annals of internal medicine.

The invisible landscape : mind, hallucinogens, and the I Ching

Terence McKenna, D. Mckenna, O. N. Oeric, 1975 .

Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat

S. Peroutka, D. Mckenna, C. R. Hekmatpanah, 1989, Neuroscience Letters.

Handbook of MEDICAL HALLUCINOGENS

Matthew W. Johnson, K. Alper, D. Presti, 2021 .